DC
AMPE

Deere & Company’s Ampio Pharmaceuticals Inc. AMPE Stock Holding History

Deere & Company’s Portfolio AMPE Stock Details AMPE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-99
Closed -$222K – 1093
2013
Q3 		$222K Hold
99
– – 0.01% 856
2013
Q2 		$171K Buy
+99
New +$157K 0.01% 900

Other funds holding AMPE

NFG
Noven Financial Group Denver, Colorado $123M AUM 5.23% 1-Year Est. Return
KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
TC
Talkot Capital Sausalito, California $73.7M AUM 8.5% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
DCM
DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
KeyBank National Association
KeyBank National Association Cleveland, Ohio $27.4B AUM 24.17% 1-Year Est. Return

Deere & Company's AMPE Position: Q4 2013 in Review

Deere & Company sold out of Ampio Pharmaceuticals Inc. (AMPE) in Q4 2013, closing a stake of 99 shares — an estimated $222K sold.

Deere & Company first reported a position in AMPE in Q2 2013 and held it in 2 quarters. The position peaked at $222K in Q3 2013. 59 funds tracked by Wall St. Rank hold AMPE as of Q4 2013.

  • Deere & Company reported no remaining Ampio Pharmaceuticals Inc. position as of Q4 2013 after selling out during the quarter.
  • Deere & Company sold 99 Ampio Pharmaceuticals Inc. shares in Q4 2013, an estimated $222K.
  • Deere & Company first reported a position in Ampio Pharmaceuticals Inc. in Q2 2013 and held it in 2 quarters.
  • Deere & Company's Ampio Pharmaceuticals Inc. position peaked at $222K in Q3 2013.
  • 59 funds tracked by Wall St. Rank held Ampio Pharmaceuticals Inc. as of Q4 2013.

Based on Deere & Company's 13F filing for Q4 2013, filed 11 Feb 2014.